au moins 24 points est considéré comme normal chez les patients dont le niveau social et culturel est dit "moyen ou supérieur", (au moins 9 ans d'études) et de 21 points chez les sujets d'un niveau social dit "inférieur ,
Rapport sur le maladie d'Alzheimer et les maladie apparentées, n°2454. Office parlementaire d'évaluation des politiques de santé, 2005. ,
Risk of dementia in diabetes mellitus: a systematic review, The Lancet Neurology, vol.5, issue.1, pp.64-74, 2006. ,
DOI : 10.1016/S1474-4422(05)70284-2
Risk of developing dementia in people with diabetes and mild cognitive impairment. The British Journal of Psychiatry, pp.36-40, 0196. ,
Four Instrumental Activities of Daily Living Score as a Predictor of One-year Incident Dementia, Age and Ageing, vol.22, issue.6, pp.457-463, 1993. ,
DOI : 10.1093/ageing/22.6.457
Impairment of Instrumental Activities of Daily Living in Patients with Mild Cognitive Impairment, Psychiatry Investigation. septembre, vol.3, issue.6, pp.180-184, 2009. ,
Neuropathological Alterations in Alzheimer Disease, Cold Spring Harbor Perspectives in Medicine, vol.1, issue.1, p.6189, 2011. ,
DOI : 10.1101/cshperspect.a006189
Alzheimer's disease. Lancet. 29 juillet, pp.387-403, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-01098836
Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer's disease, Proceedings of the National Academy of Sciences, pp.5644-51, 2006. ,
DOI : 10.1073/pnas.0600549103
Dementia and Diabetes Mellitus: Association with Apolipoprotein E4 Polymorphism from a Hospital in Southern India, International Journal of Alzheimer's Disease, vol.40, issue.3, 2012. ,
DOI : 10.1373/clinchem.2003.021683
Disturbed Neurotransmitter Transporter Expression in Alzheimer???s Disease Brain, Journal of Alzheimer's Disease, vol.26, issue.4, pp.755-66, 2011. ,
DOI : 10.3233/JAD-2011-110002
Is dopamine involved in Alzheimer's disease? " . Frontiers in Aging Neuroscience, p.252, 2014. ,
Effect of non-steroidal anti-inflammatory drugs on risk of ,
Aggregation of vascular risk factors and risk of incident Alzheimer disease, Neurology, vol.65, issue.4, pp.545-51, 2005. ,
DOI : 10.1212/01.wnl.0000172914.08967.dc
Midlife cardiovascular risk factors and risk of dementia in late life, Neurology, vol.64, issue.2, pp.277-81, 2005. ,
DOI : 10.1212/01.WNL.0000149519.47454.F2
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis, BMJ, vol.340, issue.jan12 1, p.340, 2010. ,
DOI : 10.1136/bmj.b5465
Is inhibition of the renin?angiotensin system a new treatment option for Alzheimer's disease? The Lancet Neurology, pp.373-381, 2007. ,
Cholesterol, APOE genotype, and Alzheimer disease: An epidemiologic study of Nigerian Yoruba, Neurology, vol.66, issue.2, pp.66-223, 2006. ,
DOI : 10.1212/01.wnl.0000194507.39504.17
Dementia and Alzheimer's Disease Incidence in Relationship to Cardiovascular Disease in the Cardiovascular Health Study Cohort, Journal of the American Geriatrics Society, vol.52, issue.7, pp.53-1101, 2005. ,
DOI : 10.1111/j.1532-5415.2005.53360.x
Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. The Lancet Neurology, pp.184-190, 2004. ,
The age-dependent relation of blood pressure to cognitive function and dementia. The Lancet Neurology, pp.487-99, 2005. ,
Groupe de recherche sur l'évaluation cognitive (GRECO) Le Mental-State Examination (MMSE): un outil pratique pour l'évaluation de l'état cognitif des patients par le clinicien. Version française consensuelle, Presse médicale, pp.1141-1149, 1999. ,
Les symptômes psychologiqueset comportementaux de la démence : description et prise en charge. Revue Neurologique, pp.161-357, 2005. ,
DOI : 10.1016/s0035-3787(05)85064-7
Memantine for dementia. s.l. : Cochrane Dementia and Cognitive Improvement Group, p.3154, 2004. ,
Long-term effects of A??42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial, The Lancet, vol.372, issue.9634, pp.9634-216, 2008. ,
DOI : 10.1016/S0140-6736(08)61075-2
Relation of cognitive activity to risk of developing Alzheimer disease, Neurology, vol.69, issue.20, pp.1911-1931, 2007. ,
DOI : 10.1212/01.wnl.0000271087.67782.cb
Effect of Physical Activity on Cognitive Function in Older Adults at Risk for Alzheimer Disease, JAMA, vol.300, issue.9, pp.300-1027, 2008. ,
DOI : 10.1001/jama.300.9.1027
Effect of Bright Light and Melatonin on Cognitive and Noncognitive Function in Elderly Residents of Group Care Facilities, JAMA, vol.299, issue.22, pp.299-2642, 2008. ,
DOI : 10.1001/jama.299.22.2642
Pharmacological Treatment of Neuropsychiatric Symptoms of Dementia, JAMA, vol.293, issue.5 ,
DOI : 10.1001/jama.293.5.596
Exposure to antipsychotics and risk of stroke: self controlled case series study, BMJ, vol.337, issue.aug28 2, 2008. ,
DOI : 10.1136/bmj.a1227
La qualité de vie des diabétiques de type 2 vivant en France métropolitaine: de multiples facteurs associés. Entred, pp.15-20, 2007. ,
Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus, Neurobiology of Disease, vol.37, issue.1, pp.37-67, 2010. ,
DOI : 10.1016/j.nbd.2009.09.008
Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology. Neurology. 2 septembre, pp.71-750, 2008. ,
Insulin metabolism and the risk of Alzheimer disease: The Rotterdam Study, Neurology, vol.75, issue.22, pp.1982-1987, 2010. ,
DOI : 10.1212/WNL.0b013e3181ffe4f6
The role of metabolic disorders in Alzheimer's disease and vascular dementia: two roads converged? Archives of neurology, pp.300-305, 2009. ,
Alzheimer's Disease is Type 3 Diabetes???Evidence Reviewed, Journal of Diabetes Science and Technology, vol.13, issue.11 ,
DOI : 10.1128/MCB.17.3.1595
Real-life comparison of DPP4-inhibitors with conventional oral antidiabetics as add-on therapy to metformin in elderly patients with type 2 diabetes: The HYPOCRAS study, Diabetes & Metabolism, vol.38, issue.6, pp.550-557 ,
DOI : 10.1016/j.diabet.2012.08.003
Clarifying Confusion: The Confusion Assessment Method, Annals of Internal Medicine, vol.113, issue.12, pp.1-8, 1990. ,
DOI : 10.7326/0003-4819-113-12-941
The Influence of neuropsychological functioning on neuropsychiatric problems in dementia. The Journal of Neuropsychiatry & Clinical Neurosciences, pp.50-56, 2007. ,
A Prospective Cohort Study of 358 Patients. The Journal of clinical psychiatry, pp.584-592, 2009. ,
Behavioral symptoms related to cognitive impairement, Neuropsychiatric Disease and Treatment, pp.1443-1455, 2013. ,
Intoxications graves par médicaments et substances illicites en réanimation. ScienceDirect -Réanimation 15, pp.332-342, 2006. ,
Syndromes de sevrage en réanimation. Conférence d'actualisation SFAR. Clichy : s.n, pp.243-250, 2006. ,
Échantillon national témoin représentatif des personnes diabétiques, Entred 2007-2010. Caractéristiques, état de santé, prise en charge et poids économique des personnes diabétiques, 20013. ,
L'épidémiologie des démences. La presse medicale, pp.1431-1441, 2007. ,
Symptômes comportementaux et psychologiques dans la maladied' Alzheimer : résultats de l'étude REAL.FR. La Revue de médecine interne, pp.319-324, 2003. ,
DOI : 10.1016/s0248-8663(03)80690-2
L'étude des Trois Cités: relation entre pathologie vasculaire et démence. Revue médicale de l'Assurance Maladie. avril-juin, pp.2-117, 2006. ,
Cholesterol and Alzheimer's disease -is there a relation? Mechanisms of Ageing and Development, pp.138-185, 2006. ,
Mild cognitive impairment and Dementia: The importance of modifiable risk factors. Deutsches Ärzteblatt International, 2011. ,
Effectiveness of the Combination of Memantine Plus Vitamin D on Cognition in Patients With Alzheimer Disease, Cognitive And Behavioral Neurology, vol.25, issue.3, pp.25-121 ,
DOI : 10.1097/WNN.0b013e31826df647
The REAL.FR Research Program on Alzheimer's disease and its management: Methods and preliminary results, The Journal of Nutrition, Healt & Aging, vol.7, issue.2, 2003. ,
Présentation clinique et pièges diagnostiques de l'épilepsie du sujet âgé ,
Continuer ou arrêter les neuroleptiques chez des patients déments ? www.minerva-ebm.be/fr, 2009. ,
Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and Diabetes Mellitus type-2, Journal of the Neurological Sciences, vol.288, issue.1-2, pp.112-116, 2010. ,
DOI : 10.1016/j.jns.2009.09.022
Lactic Acidosis in Patients with Diabetes Treated with Metformin, New England Journal of Medicine, vol.338, issue.4, pp.265-271, 1998. ,
DOI : 10.1056/NEJM199801223380415
Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long-acting versus short-acting sulphonylureas, Diabetic Medicine, vol.116, issue.7, pp.586-90, 1999. ,
DOI : 10.1016/S0895-4356(97)00024-3
Antipsychotic Therapy and Short-term Serious Events in Older Adults With Dementia. Archives of Internal Medicine, pp.168-1090, 2008. ,
Impact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adults, Pharmacoepidemiology and Drug Safety, vol.53, issue.12, pp.1248-55 ,
DOI : 10.1002/pds.2031
Management of Alzheimer disease. La Presse Médicale, pp.10-12, 2007. ,
Impact of Antidiabetic Medications on Physical and Cognitive Functioning of Older Mexican Americans with Diabetes Mellitus, Annals of Epidemiology, vol.13, issue.5, pp.369-376, 2003. ,
DOI : 10.1016/S1047-2797(02)00464-7
Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life, Psychological Medicine, vol.33, issue.7, pp.33-1223, 2003. ,
DOI : 10.1017/S0033291703008213
Sundowning and circadian rhythms in ,
High dose B vitamin supplementation and cognitive decline in Alzheimer's disease: A randomized controlled trial, Journal of the American Medical Association, vol.15, issue.15, pp.300-1774, 2008. ,
Hypoglycaemic episodes and risk of dementia in diabetes mellitus: 7-year follow-up study, Journal of Internal Medicine, vol.108, issue.Suppl. 2, pp.273-102 ,
DOI : 10.1111/joim.12000
Glucose Levels and Risk of Dementia. The New England Journal of Medicin, pp.540-548, 2013. ,
Hypoglycemic Episodes and Risk of Dementia in Older Patients With Type 2 Diabetes Mellitus, JAMA, vol.301, issue.15, pp.1565-1572, 2009. ,
DOI : 10.1001/jama.2009.460
Multiple cognitive deficits during the transition to ,
Evaluation de l'autonomie, Les activités instrumentales de la vie quotidienne, IADL. [éd.] Médicales. L'évaluation clinique standardisée en psychiatrie, pp.477-480, 1996. ,
Confusion Assessment Method ou CAM, un outil pour le diagnostic de la confusion mentale chez les sujets âgés. La revue de gériatrie, pp.713-715, 2008. ,
The REALFR Research Program on Alzheimer's disease and its management: Methods and Preliminary Results, The Journal of Nutrition Health and Aging, vol.7, p.2, 2003. ,
Les anticholinest??rasiques en??soins de??longue dur??e??: analyse des??pratiques actuelles ????partir d'une????tude observationnelle francoqu??b??coise, La Revue de M??decine Interne, vol.27, issue.8, pp.588-594, 2006. ,
DOI : 10.1016/j.revmed.2006.04.012
Présentation de l'étude multicentrique en réseau. Facteurs prédictifs d'hospitalisation et filières de soins chez des patients atteints de la maladie d'Alzheimer (REAL.FR). La revue de médecine interne, pp.24-278, 2003. ,
Prévalence de la démence et de la maladie d'Alzheimer chez les personnes de 75 ans et plus : données réactualisées de la cohorte PAQUID, Revue Neurologique, vol.159, pp.4-405 ,
Épidémiologie des démences et de la maladie d'Alzheimer. Bulletin épidémiologique hebdomadaire (BEH), pp.42-44, 2006. ,
Standards of medical care in diabetes. Diabetes Care, pp.31-43, 2008. ,